Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Draegerwerk AG KGaADGWPF 70 EV-to-EBITDA is 6.69 as of Aug. 16, 2026, which is 10% above its 10-year median of 6.06. GuruFocus rates DGWPF with a GF Score™ of 70/100 and a GF Value™ of $61.04 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 513 Medical Devices & Instruments companies, Draegerwerk AG KGaA ranks better than 82.46% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Draegerwerk AG KGaA's enterprise value is $2,249 Mil.
Draegerwerk AG KGaA's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was $336 Mil. Therefore, Draegerwerk AG KGaA's EV-to-EBITDA for today is 6.69.
The historical rank and industry rank for Draegerwerk AG KGaA's EV-to-EBITDA or its related term are showing as below:
DGWPF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -63 Med: 6.06 Max: 22.49
Current: 6.77
During the past 13 years, the highest EV-to-EBITDA of Draegerwerk AG KGaA was 22.49. The lowest was -63.00. And the median was 6.06.
DGWPF's EV-to-EBITDA is ranked better than 82.46% of 513
companies
in the Medical Devices & Instruments industry
Industry Median: 14.95
vs DGWPF: 6.77
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Draegerwerk AG KGaA (OTCPK:DGWPF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Draegerwerk AG KGaA's PE Ratio (TTM) for today is calculated as:
Draegerwerk AG KGaA's share price for today is $93.00.
Draegerwerk AG KGaA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $10.646.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Draegerwerk AG KGaA's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Draegerwerk AG KGaA's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Draegerwerk AG KGaA EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Draegerwerk AG KGaA's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Draegerwerk AG KGaA's EV-to-EBITDA falls into.
Draegerwerk AG KGaA's current Enterprise Value is $2,249 Mil.
Draegerwerk AG KGaA's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $336 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Draegerwerk AG KGaA (DGWPF) has a EV-to-EBITDA of 6.69 as of Aug. 16, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Draegerwerk AG KGaA. This is 10% above median its historical median of 6.06. According to the industry distribution chart, Draegerwerk AG KGaA ranks #90 out of 513 companies in the Medical Devices & Instruments industry, placing it in the top 17.5%.
Is Draegerwerk AG KGaA's EV-to-EBITDA too high?
Draegerwerk AG KGaA's current EV-to-EBITDA of 6.69 is 10% above median its 10-year median of 6.06. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.95. Draegerwerk AG KGaA's value of 6.69 is 55.3% below this industry median. Based on the distribution chart, Draegerwerk AG KGaA ranks #90 out of 513 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Draegerwerk AG KGaA has a GF Score™ of 70/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Draegerwerk AG KGaA's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Draegerwerk AG KGaA ranks #90 out of 513 companies for EV-to-EBITDA. This places Draegerwerk AG KGaA in the top 18% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 14.95. Draegerwerk AG KGaA's value of 6.69 is 55.3% below this benchmark. While the company's 10-year median is 6.06 vs. the industry median of 14.95, Draegerwerk AG KGaA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.95, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Draegerwerk AG KGaA's current EV-to-EBITDA of 6.69 is 55.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Draegerwerk AG KGaA. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Draegerwerk AG KGaA's current EV-to-EBITDA is 6.69, which is 10% above median its own 10-year median of 6.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Draegerwerk AG KGaA stock overvalued right now?
Based on GuruFocus' analysis, Draegerwerk AG KGaA (DGWPF) is currently considered Significantly Overvalued. The stock's GF Value™ is $61.04, compared to a current price of $93.00 — trading 52.4% above its estimated fair value. The current EV-to-EBITDA is 6.69, which is 10% above median its 10-year median of 6.06 and 55.3% below the Medical Devices & Instruments industry median of 14.95. Draegerwerk AG KGaA's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Draegerwerk AG KGaA (DGWPF), the current EV-to-EBITDA is 6.69 as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Draegerwerk AG KGaA (DGWPF) Overvalued in 2026?
Based on GuruFocus' analysis, Draegerwerk AG KGaA stock appears to be overvalued.
The current stock price of $93.00 is trading 52.4% above its estimated GF Value™ of $61.04.
GuruFocus considers Draegerwerk AG KGaA to be Significantly Overvalued.
Key valuation signals for DGWPF:
EV-to-EBITDA: 6.69 (10% above median its 10-year median of 6.06)
GF Value™: $61.04 vs. price of $93.00 (52.4% above fair value)
Industry Position: 55.3% below the Medical Devices & Instruments median (#90 of 513)
No single metric tells the full story. See the DGWPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Draegerwerk AG & Co KGaA develops medical and safety equipment for clinical and industrial applications. The firm operates in two segments: medical and safety. The medical division contributes the majority of revenue, it develops and produces system solutions, equipment, and services for the acute point of care, it has five business units Therapy, Hospital Consumables & Accessories, Workplace Infrastructure, Monitoring, and Data Business. Its safety division develops and produces devices, system solutions, and services for personal protection, gas detection, and integrated hazard management. Its geographical segments are Europe; Germany; the Americas; Africa, Asia, and Australia.
70GF Score
Get the complete analysis for DGWPF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DGWPF has been successfully added to your 
